Masetti M, Al-Batran SE, Goetze TO, Thuss-Patience P, et al. Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy. Int J Cancer 2024;154:2142-2150.
PMID: 38447003